Sanderling Ventures Management V - Net Worth and Insider Trading
Sanderling Ventures Management V Net Worth
The estimated net worth of Sanderling Ventures Management V is at least $4 Million dollars as of 2024-09-20. Sanderling Ventures Management V is the 10% Owner of Endocyte Inc and owns about 184,169 shares of Endocyte Inc (ECYT) stock worth over $4 Million. Details can be seen in Sanderling Ventures Management V's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sanderling Ventures Management V has not made any transactions after 2011-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sanderling Ventures Management V
Sanderling Ventures Management V Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sanderling Ventures Management V owns 2 companies in total, including Chimerix Inc (CMRX) , and Endocyte Inc (ECYT) .
Insider Ownership Summary of Sanderling Ventures Management V
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2013-04-10 | 10 percent owner |
| ECYT | Endocyte Inc | 2012-12-11 | 10 percent owner |
Sanderling Ventures Management V Latest Holdings Summary
Sanderling Ventures Management V currently owns a total of 1 stock. Sanderling Ventures Management V owns 184,169 shares of Endocyte Inc (ECYT) as of December 21, 2011, with a value of $4 Million.
Latest Holdings of Sanderling Ventures Management V
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECYT | Endocyte Inc | 2011-12-21 | 184,169 | 23.99 | 4,418,214 |
Holding Weightings of Sanderling Ventures Management V
Sanderling Ventures Management V Form 4 Trading Tracker
According to the SEC Form 4 filings, Sanderling Ventures Management V has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the acquisition of 4,400 shares on December 21, 2011, which cost Sanderling Ventures Management V around $13,992.
Insider Trading History of Sanderling Ventures Management V
- 1
Sanderling Ventures Management V Trading Performance
GuruFocus tracks the stock performance after each of Sanderling Ventures Management V's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sanderling Ventures Management V is 68.05%. GuruFocus also compares Sanderling Ventures Management V's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sanderling Ventures Management V within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sanderling Ventures Management V's insider trading performs compared to the benchmark.
Performance of Sanderling Ventures Management V
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.18 | | | | | |
| Relative Return to S&P 500(%) | 5.42 | | | | | |
Sanderling Ventures Management V Ownership Network
Sanderling Ventures Management V Owned Company Details
What does Chimerix Inc do?
Who are the key executives at Chimerix Inc?
Sanderling Ventures Management V is the 10 percent owner of Chimerix Inc. Other key executives at Chimerix Inc include Chief Business Officer Michael T. Andriole , Principal Accounting Officer David Jakeman , and director & Chief Executive Officer Michael A. Sherman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, Sanderling Ventures Management V made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 60,000 shares made by Fred A Middleton , a net sale of 6,270 shares made by David Jakeman , and a net sale of 3,029 shares made by Michael T. Andriole .
In summary, during the past 3 months, insiders sold 1,285 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 1,285 shares. During the past 18 months, 11,239 shares of Chimerix Inc (CMRX) were sold and 173,750 shares were bought by its insiders, resulting in a net purchase of 162,511 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
Sanderling Ventures Management V Mailing Address
Above is the net worth, insider trading, and ownership report for Sanderling Ventures Management V. You might contact Sanderling Ventures Management V via mailing address: 400 South El Camino Real Ste 1200, San Mateo Ca 94402-1708.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
